{
    "2018-02-08": [
        [
            {
                "time": "2018-01-02",
                "original_text": "A Look at Ablynx and Sanofi’s Existing Partnership",
                "features": {
                    "keywords": [
                        "Ablynx",
                        "Sanofi",
                        "partnership"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare",
                        "biotech"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "none"
                }
            },
            {
                "time": "2018-01-03",
                "original_text": "Highlights of Sanofi’s 3.9 Billion Euro Ablynx Acquisition",
                "features": {
                    "keywords": [
                        "Sanofi",
                        "Ablynx",
                        "acquisition",
                        "3.9 billion euro"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare",
                        "biotech"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-01-04",
                "original_text": "Analysts’ Updates after Sanofi’s Bioverativ Announcement",
                "features": {
                    "keywords": [
                        "analysts",
                        "updates",
                        "Sanofi",
                        "Bioverativ"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "healthcare",
                        "pharmaceuticals"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "none",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            }
        ]
    ]
}